Mucus hypersecretion in COPD: should we only rely on symptoms?

Burgel P-R., Martin C.

Source: Eur Respir Rev 2010; 19: 94-96
Journal Issue: June 2010 - 19 (116)
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Burgel P-R., Martin C.. Mucus hypersecretion in COPD: should we only rely on symptoms?. Eur Respir Rev 2010; 19: 94-96

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic mucus hypersecretion in severe asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017

Revisited role for mucus hypersecretion in the pathogenesis of COPD
Source: Eur Respir Rev 2009; 19: 109-112
Year: 2010



Bronchial asthma: what is different in patients with and without chronic cough?
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Mucus hypersecretion: a common symptom, a common mechanism?
Source: Eur Respir J 2004; 23: 797-798
Year: 2004


Mucus and microbes: why does bronchiectasis develop?
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020


Chronic mucus hypersecretion in asthma: Relation to smoking status and disease severity
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD
Source: Eur Respir J 2015; 45: 60-75
Year: 2015



Cough: physiology and pathophysiology
Source: Annual Congress 2005 - Management of airway hypersecretions
Year: 2005

Airway hyperresponsiveness: the riddle of asthma and COPD
Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics
Year: 2017


Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Decametoxine influence on bronchial hyperreactivity in patients with bronchial asthma
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014


Influence of obesity and nasal polyps on severe asthma
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Does dyspnea perception match the severity of airway obstruction in COPD outpatients?
Source: Eur Respir J 2004; 24: Suppl. 48, 57s
Year: 2004

Bronchial hyperresponsiveness as a predictor of treatment-response in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


May impairment of mucociliary clearance in COPD be reversible?
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013


Determinants of fatigue in patients with bronchial asthma
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015

Irreversible airways obstruction on spirometry, does it equate to a diagnosis of COPD?
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012

Airway mucus accumulation in COPD: the cholinergic paradox!
Source: Eur Respir J, 55 (1) 1902473; 10.1183/13993003.02473-2019
Year: 2020